跳至主要内容
临床试验/CTRI/2018/01/011403
CTRI/2018/01/011403已完成4 期

Evaluation of â??Quality of Lifeâ?? and in-use tolerance in women with facial melasma, after using a triple combination drug (TRI-LUMA Cream)

Galderma India Private Limited0 个研究点目标入组 33 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Participants with moderate to severe melasma on the face.
  • Childbearing potential patient with highly effective contraceptive methods
  • Willing to avoid unusual sun exposure as far as possible for the entire study duration.

排除标准

  • Patients with prior history of mometasone based triple combination melasma therapy or under hormonal replacement therapy including usage of OC pills
  • If Patients were immunocompromised or were under immunosuppressive treatment, or had contraindications for corticosteroid treatment

研究者

相似试验

To study Quality of Life and untoward effects of... | 临床试验